AU766012B2 - Method and disposable devices for micro extraction - Google Patents
Method and disposable devices for micro extraction Download PDFInfo
- Publication number
- AU766012B2 AU766012B2 AU16986/00A AU1698600A AU766012B2 AU 766012 B2 AU766012 B2 AU 766012B2 AU 16986/00 A AU16986/00 A AU 16986/00A AU 1698600 A AU1698600 A AU 1698600A AU 766012 B2 AU766012 B2 AU 766012B2
- Authority
- AU
- Australia
- Prior art keywords
- liquid
- container
- extraction
- analyte
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000004853 microextraction Methods 0.000 title claims description 36
- 238000000034 method Methods 0.000 title claims description 31
- 238000000605 extraction Methods 0.000 claims description 61
- 239000012491 analyte Substances 0.000 claims description 55
- 239000007788 liquid Substances 0.000 claims description 53
- 239000012488 sample solution Substances 0.000 claims description 37
- 239000012528 membrane Substances 0.000 claims description 34
- 239000000835 fiber Substances 0.000 claims description 23
- 238000003756 stirring Methods 0.000 claims description 10
- 238000004458 analytical method Methods 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 229920000642 polymer Polymers 0.000 claims description 7
- 239000012472 biological sample Substances 0.000 claims description 3
- UZHDGDDPOPDJGM-UHFFFAOYSA-N Stigmatellin A Natural products COC1=CC(OC)=C2C(=O)C(C)=C(CCC(C)C(OC)C(C)C(C=CC=CC(C)=CC)OC)OC2=C1O UZHDGDDPOPDJGM-UHFFFAOYSA-N 0.000 claims 1
- 239000000523 sample Substances 0.000 description 50
- 239000002904 solvent Substances 0.000 description 42
- 239000000243 solution Substances 0.000 description 34
- 239000012071 phase Substances 0.000 description 25
- 238000005192 partition Methods 0.000 description 18
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 14
- 239000013060 biological fluid Substances 0.000 description 10
- 238000002347 injection Methods 0.000 description 10
- 239000007924 injection Substances 0.000 description 10
- 238000002470 solid-phase micro-extraction Methods 0.000 description 10
- 238000000638 solvent extraction Methods 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 239000011159 matrix material Substances 0.000 description 9
- 239000011148 porous material Substances 0.000 description 9
- 210000002700 urine Anatomy 0.000 description 9
- 238000000622 liquid--liquid extraction Methods 0.000 description 8
- 239000003960 organic solvent Substances 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- -1 polyethylene Polymers 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 239000002594 sorbent Substances 0.000 description 5
- 239000004743 Polypropylene Substances 0.000 description 4
- 238000011953 bioanalysis Methods 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- MWQCHHACWWAQLJ-UHFFFAOYSA-N Prazepam Chemical compound O=C1CN=C(C=2C=CC=CC=2)C2=CC(Cl)=CC=C2N1CC1CC1 MWQCHHACWWAQLJ-UHFFFAOYSA-N 0.000 description 3
- 239000008351 acetate buffer Substances 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 238000002045 capillary electrochromatography Methods 0.000 description 3
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 3
- 229960003529 diazepam Drugs 0.000 description 3
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 3
- 229960000520 diphenhydramine Drugs 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 229960004856 prazepam Drugs 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 238000005251 capillar electrophoresis Methods 0.000 description 2
- 238000005515 capillary zone electrophoresis Methods 0.000 description 2
- 238000013375 chromatographic separation Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 238000004094 preconcentration Methods 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000012088 reference solution Substances 0.000 description 2
- 229920001780 ECTFE Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920006355 Tefzel Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 229940090047 auto-injector Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 150000001557 benzodiazepines Chemical class 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- QHSJIZLJUFMIFP-UHFFFAOYSA-N ethene;1,1,2,2-tetrafluoroethene Chemical compound C=C.FC(F)=C(F)F QHSJIZLJUFMIFP-UHFFFAOYSA-N 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000001012 micellar electrokinetic chromatography Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920003053 polystyrene-divinylbenzene Polymers 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000004454 trace mineral analysis Methods 0.000 description 1
- 239000012855 volatile organic compound Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4005—Concentrating samples by transferring a selected component through a membrane
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4005—Concentrating samples by transferring a selected component through a membrane
- G01N2001/4016—Concentrating samples by transferring a selected component through a membrane being a selective membrane, e.g. dialysis or osmosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4055—Concentrating samples by solubility techniques
- G01N2001/4061—Solvent extraction
Landscapes
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Sampling And Sample Adjustment (AREA)
- Extraction Or Liquid Replacement (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Description
WO 00/33050 PCT/N099/00359 METHOD AND DISPOSABLE DEVICES FOR MICRO EXTRACTION The present invention relates generally to extraction technology.
More specifically the invention relates, in a first aspect, to an apparatus having disposable elements for carrying out liquid-liquid micro extraction and liquid-liquidliquid micro extraction.
The invention further relates to methods for liquid-liquid micro extraction and liquidliquid-liquid micro extraction whereby there is obtained a high enrichment of analyte in the acceptor solution.
Finally, the invention relates to a special disposable device for use in liquid-liquid micro extraction.
With regard to liquid-liquid micro extraction, this relates especially to extraction of an analyte from an aqueous sample solution to an organic solvent where the analyte is enriched in the organic solvent.
Where the aforementioned liquid-liquid-liquid micro extraction is concerned, an analyte is extracted from an aqueous sample solution through a water immiscible liquid to an aqueous acceptor solution.
Introduction In capillary separation methods such as gas chromatography capillary electrophoresis capillary electrochromatography (CEC) and micro high performance liquid chromatography (HPLC) injection volumes are in the nl to jL1 range. Sample pretreatment is necessary when these methods are used to determine analytes in complex matrices such as biological fluids. The principal objectives of sample pre-treatment involves concentration of the analytes to a concentration suitable for detection and removal of as many interfering compounds as possible. The use of an extraction technique is common in the pre-treatment of most types of samples. Sample extraction is the most tedious and time consuming step in the analysis of drugs present in the pg/ml to pgg/ml range of biological fluids such as blood, serum, plasma, or urine.
WO 00/33050 PCT/N099/00359 2 No sample preparation technique is able to trap analytes in 1 50 il of solvent for direct injection into the analytical instrument. Ideally the analytes should be trapped in an organic solvent for injection into a GC instrument and in an aqueous solvent for injection into a CE instrument or a micro HPLC instrument. The most frequently used extraction techniques are liquid-liquid extraction (LLE) and solid-phase extraction (SPE). The primary goal of these extraction techniques is to extract the analytes quantitatively from the analytical matrix. When these techniques are used the analytes are normally collected in 0.2 10 ml of extraction solvent.
Quantitative extraction in LLE can only be achieved by using large volumes of extraction solvent relative to the sample volume. For the extraction of a 1 ml sample of a biological fluid 0.5 10 ml of extraction solvent is used. In order to obtain enrichment the extract is evaporated and the analytes reconstituted in a smaller amount of solvent.
In SPE the final extraction volume is governed by the bed volume. The bed volume is the amount of solvent required to fill all the internal pores and interstitial spaces of the particles. For a 40 micron, 60 Angstrom sorbents, bed volumes are in the order of 120 .tl per 100 mg of sorbent. A 1 ml sample of a biological fluid is normally extracted on 100 mg sorbent. The minimum elution volume required is 2 bed volumes or 0.24 ml of solvent. The consequence is that a maximum of 4 times enrichment is obtainable in SPE of a 1 ml sample. In order to achieve higher enrichments the elution solvent must be evaporated and the analyte reconstituted in a smaller volume of solvent.
Due to practical limitations it is difficult to reconstitute a sample in solvent volumes smaller than 100 .ll. When the analyte is reconstituted in 100 tl of solvent, analyte concentration will not exceed 10 times the analyte concentration in a 1 ml sample.
Higher enrichments are often necessary to detect trace amounts of analytes by the capillary separation methods. This fact greatly reduces the applicability of the capillary separation methods in bioanalysis.
Micro extraction A solution to this problem is to apply a micro extraction (ME) technique, in which the analytes are extracted from a large volume of sample solution into a small volume of an acceptor phase. The acceptor phase can either be a solid such as in solid-phase micro extraction (SPME), or an organic solvent such as in liquid-liquid micro extraction (LLME). A large sample volume is used in order to collect quantifiable amounts of the WO 00/33050 PCT/N099/00359 3 analytes and enrichment is facilitated by trapping the analytes in the small volume of the acceptor phase. The extraction is carried out until equilibrium.
Figure 1 illustrates the difference between traditional LLE and LLME. A 1 ml sample containing 1 pg/ml of the analyte is extracted into 1 ml of solvent in LLE and into 10 l.1 of solvent in LLME. The analyte partition coefficient between the aqueous matrix and the organic solvent is 100. Figure 1 shows that 0.99 )pg of the analyte is extracted into the organic extract by LLE and that 0.0099 gg remains in the sample. Analyte concentration in the extract is 0.99 [pg/ml. In LLME 0.5 pg of the analyte is extracted into the organic acceptor phase while 0.5 p.g remains in the sample. Sample concentration in the acceptor phase is 50 gg/ml. This fact demonstrates that very high enrichments are obtainable in LLME without solvent evaporation and reconstitution.
SPME is a well established solvent free sample preparation technique. In SPME the acceptor phase is a solid polymer coated on a fibre. The polymeric acceptor phase is non-volatile and acts as a sorbent for partitioning of the analytes. The volume of the polymeric acceptor phase is less than 1 pl. SPME was originally developed for the analysis of organic compounds in water samples and the method is particularly useful for trace analysis of volatile organic compounds prior to GC analysis. When SPME is applied to bioanalytical samples such as plasma or urine several difficulties are observed. In drug analysis enrichment from a biological matrix is greatly reduced as compared to enrichment from a pure water sample. This is due to reduced capacity of the acceptor phase. In addition the polymeric acceptor phase is easily contaminated when SPME is applied to bioanalysis and cross contamination between samples may easily occur. These facts greatly limit the applicability of SPME in bioanalysis. A solution to this problem is to apply a LLME technique.
Basic principles of LLME The basic theory of SPME is well documented and is applicable to LLME. If we define the acceptor/sample partition coefficient as Kas the volume of acceptor solution as Va, the volume of sample solution as Vs and the initial sample concentration as Co, the amount of analyte trapped in the acceptor phase, n, is shown in equation 1: WO 00/33050 PCT/N099/00359 4 Kas Va V Co 1. n= Kas Va V The concentration of analyte trapped in the acceptor phase, Ca, is: 2. Ca n/Va When Kas Va Vs the amount of analyte collected in the acceptor phase is: 3. n Kas Va Co and Ca Kas Co.
Table 1 shows the equilibrium concentration of the analyte trapped in 0.001 ml 1 ml of acceptor phase after extraction of a 1 ml sample solution containing 1 jtg/ml of the analyte. The partition coefficients are 10,100 ,1000 and oo.
Table 1. Concentration of analyte trapped in variable volumes of acceptor solution with partition coefficients ranging from 10 oo.
Volume of acceptor phase (ml) Concentration of analyte in the acceptor phase (plg/ml) K=10 K=100 K= 1000 oo 0.001 0.01 0.025 0.05 0.1 1 9.9 9 8 6.7 5 1.7 0.91 91 50 28.6 16.7 9.1 1.9 0.99 500 91 38.5 19.6 9.9 2.0 1 1000 100 1 The concentrations shown in Table 1 demonstrate that as long as the partition coefficients are high, the enrichments obtained by LLME into 0.001 0.05ml of acceptor phase are superior to the enrichments obtained by traditional extraction methods.
WO 00/33050 PCT/NO99/00359 There are, however, practical problems related to extraction of biological fluids with small volumes of organic solvents. In biological fluids an emulsion is readily formed during liquid-liquid extraction and small volumes of solvent are easily emulsified. Even after centrifugation small solvent volumes are difficult to collect. Extraction of biological fluids with solvent volumes less than 50 L1 is therefore not performed in traditional analytical procedures.
One possible way to solve these problems is to use so-called disposable sponges or to use the devices described in the attached Figures 3 and 4.
Disposable extraction sponges The problems mentioned above can be solved by disposable extraction sponges.
Disposable extraction sponges are used to immobilise 10 50 1 of extraction solvent.
LLME with extraction sponges is particularly suited for sample preparation of biological fluids prior to GC analysis. Solvent immobilised into extraction sponges eliminates the handling problems encountered with small solvent volumes since immobilised solvents are not emulsified and are easily collected after extraction.
Materials used in the manufacture of extraction sponges should be solvent resistant, porous and compressible. In addition the materials should be sufficiently hydrophobic to immobilise water immiscible solvents. The pore size may range from a few micrometers up to millimeters. Expanded polymers and polymeric foams are particularly suited.
Examples of solvent resistant polymers are Teflon, Tefzel, Halar, polyethylene and polypropylene. The size of the polymeric material is cut to fit immobilisation of a predetermined volume of solvent.
LLME with disposable extraction sponges The extraction sponges are filled into a container with the solvent to be immobilised.
The sponges are compressed to remove air trapped in the pores and are thereafter soaked in the solvent. The sponges are then ready for extraction.
The sample solutions are filled into extraction vials. Typical volumes of sample solution are 0.5 5 ml. Quantitative analysis is always performed by adding an internal standard to the sample solution. The internal standard is added to the sample prior to the extraction and follows the analyte through all the analytical steps. The internal standard compensates for all fluctuations in the procedure. The chemical nature of the sample is WO 00/33050 PCT/N099/00359 6 altered prior to extraction to facilitate analyte extraction into the organic solvent. This involves optimisation of pH and addition of salt.
One solvent sponge with immobilised solvent is removed from the container and added to the extraction vial. Extraction is performed by stirring. Any kind of stirring, for example, a magnetic stir bar, can be used. The extraction is continued until equilibrium 30 min). The solvent sponge is then removed from the sample vial. Immobilised solvent with the enriched analyte is liberated by compression. Compression can be facilitated in any device suitable for squeezing. For example the sponge can be compressed in a disposable medical syringe equipped with a needle and the liberated solvent is filled into micro sampling vials made to fit into a GC autoinjector.
Sponges able to immobilise 25 ul of solvent are suitable in many applications. As shown in Table 1 enrichments of 30 are obtained for analytes having a partition coefficient of 100. A solvent volume of 25 ul is sufficiently large to allow easy handling. This solvent volume is also large enough to avoid overloading and reduced enrichment during extraction. One sponge is used for each sample and used sponges can be stored safely in a container prior to destruction. Compared to traditional methods for sample preparation, LLME with solvent sponges greatly reduces solvent consumption and hazards to workers and the environment.
The present invention aims to solve the problem introduced above by utilising so-called micro back extraction, referred to above and hereinafter as liquid-liquid-liquid micro extraction (LLLME), to obtain a sufficiently high concentration of the material to be analysed in the acceptor solution.
The principles of LLLME will be explained in more detail below.
Liquid-liquid-liquid micro extraction (LLLME) Separation techniques used in capillary electrophoresis such as capillary zone electrophoresis, micellar electrokinetic chromatography and capillary electrochromatography favour injection of low ionic strength aqueous samples. Due to the injection of nl volumes of samples, high enrichments are required in bioanalysis of drugs present in trace amounts in biological fluids.
Most drugs are ionic. Ionic organic substances can be enriched by LLLME. The principle of LLLME for isolation of ionic organic molecules is illustrated in Figure 2.
WO 00/33050 PCT/N099/00359 7 Clean-up and concentration of analytes are based on partitioning of the analytes from a large volume of the aqueous sample matrix through a membrane and into a small volume of an aqueous acceptor phase. The membrane acts as a clean-up barrier between two aqueous phases. Both basic and acid compounds can be enriched with LLLME. The pH of the matrix is adjusted so that the analytes are uncharged. This permits them to pass through the membrane into the aqueous acceptor solution on the other side. The pH of the acceptor solution is adjusted to a pH where the analytes are ionised, thus preventing them from re-entering the membrane. Only small uncharged molecules can pass through the membrane and only molecules which are soluble in the membrane and in the acceptor solution can be enriched. Water soluble neutral substances remain in the matrix. Neutral hydrophobic substances partition into the membrane and not into the acceptor phase. Substances with the opposite charge as the analytes remain in the matrix. LLLME is thus a powerful clean-up technique.
The driving force for the extraction is dependant on the product of the analyte partition coefficients between the membrane and the sample solution and between the acceptor phase and the membrane which is equivalent to the analyte partition coefficient between the acceptor phase and the sample matrix. Compounds having a large partition coefficient between the two aqueous phases will be enriched. This partition coefficient will be large for many drugs. LLLME therefore has the potential to act as both a powerful enrichment and clean-up technique for many ionic drugs.
If we define the acceptor/membrane partition coefficient as Kal, the membrane/sample partition coefficient as Kls, the acceptor/sample partition as Kas, the acceptor volume as Va, the membrane volume as Vl, the sample volume as Vs, and the initial sample concentration as Co, the amount of analyte extracted by LLMBE, n, is: Kal Kls Va Vs Co Kas Va Vs Co 4. n= Kal Kls Va Kls Vi Vs Kas Va Kls Vi Vs In LLLME the membrane volume should be as small as possible. Then Kls Vl will be negligible and equation 4 can be reduced to Kas Va Vs Co n= Kas Va Vs 8 Equation 5 can be used to estimate analyte enrichment from a 1 ml sample solution containing I pg/ml of the analyte as a function of acceptor phase volume and the partition coefficient. The results obtained are equivalent to the results shown in Table 1 showing that enrichments from a 1 ml sample into 0.001-0.05 ml of acceptor solution are superior to the enrichments obtained by traditional extraction methods.
Many ionic drugs have partition coefficients larger than 100 between two aqueous phases: one having a pH where the drugs are charged and the other a pH where the drugs are uncharged. When an analyte with a partition coefficient of 100 is trapped in p.1 acceptor solution from 1 ml sample with a concentration of 1 p.g/ml, analyte concentration in the acceptor phase is 50 gg/ml. This fact demonstrates that LLLME is able to provide enrichments not obtainable by any other extraction method. LLLME is therefore particularly useful as an extraction technique for modem capillary separation methods such as CE.
The chemical nature of the membrane is important in obtaining short analysis times.
Extractions should be continued until equilibrium between the three phases is established. If the membrane/sample partition coefficient is low, equilibrium times will be long and will approach infinity for analytes which are very poorly soluble in the °membrane. The solvent forming the membrane should therefore be a good solvent for °the target analyte. The chemical nature of the membrane is also important for tuning df the selectivity.
The present invention aims to improve the known art and to utilise the above suggested possibilities and therefore relates, in a first aspect, to an apparatus for carrying out liquid-liquid micro extraction or liquid-liquid-liquid micro extraction with high enrichment, the apparatus including a) a container for a sample solution having volume Vs with dissolved substance, analyte, to be analysed, b) a second container arranged in the first container, preferably a disposable container, having permeable membrane walls, for an acceptor solution, having volume Va, wherein 1) Vs:Va 50 and 2) about 1 gl Va 50 .l, c) stirring means, preferably a magnetic bar.
In one embodiment the container for the acceptor solution is a microporous hollow fibre, optionally of an active polymer.
As mentioned in the introduction, the invention also relates to methods for extraction and thereby relates, in a first extraction aspect, to a method for liquid-liquid micro extraction with high enrichment by using the above described apparatus,: whe re in a) the container for acceptor solution is lowered into an acceptor solution so that the membrane wall is impregnated with, and the container is filled with, a defined volume of the acceptor solution, b) the container filled under a) is transferred to the container having a defined volume of the sample solution with the analyte that is sought, c) the sample solution with analyte is stirred until extraction equilibrium is established for the analyte in the two solutions, and d) the acceptor solution containing enriched analyte is removed from its container for analysis of the analyte.
In a second extraction aspect, the invention relates to a method for liquid-liquid-liquid micro extraction with high enrichment by the use of the apparatus according to claim 1, wherein a) the walls of the container for the acceptor solution are impregnated with, for immobilisation of, a liquid that is immiscible with the sample solution and the acceptor solution, b) the container for acceptor solution is filled with a defined volume thereof and c) is lowered into the container having a defined volume of the sample solution with the analyte that is sought, d) the sample solution with analyte is stirred until extraction equilibrium is established between i) the sample solution and the immobilised liquid, and ii) the immobilised liquid and the acceptor solution, and e) the acceptor solution with enriched analyte is removed from its container for analysis of the analyte.
The latter method is particularly suited for enrichment of acidic or basic analytes. For example, basic analytes can be enriched from basic, aqueous, biological samples by utilising an acceptor liquid in the form of an acidified, aqueous liquid and an organic liquid immobilised in the membrane that is immiscible with the aqueous liquids.
Here, as mentioned previously, it may be advantageous to use a microporous hollow fibre, but it is also possible to use an active polymer.
In a final aspect, as mentioned above, the invention relates to a disposable device for use in liquid-liquid micro extraction having the form of a sponge-like body having a defined pore volume for absorption of an immobilised acceptor solution for an analyte from a volume of a sample solution.
The invention will now be illustrated in more detail with reference to the accompanying drawings where: Figure 1 shows a comparison between liquid-liquid extraction and liquid-liquid micro extraction, Figure 2 shows the principle for liquid-liquid-liquid micro extraction, Figure 3 shows a possible device for utilisation in LLLME, or LLME, Figure 4 shows another possible device for LLLME, or LLME, Figure 5 shows chromatograms obtained in connection with Example 1, and Figure 6 shows electropherograms obtained in connection with Example 2.
Disposable devices for LLLME Devices for LLLME should accomplish extraction from a large sample volume through a negligible volume of a membrane into a small volume of an aqueous acceptor solution. The membrane should be a thin film with a large surface area. The membrane can either be a solid (liquid-solid-liquid micro extraction, LSLME) or a liquid (liquidliquid-liquid micro extraction, LLLME).
In LLLME the solvent forming the liquid membrane should be immobilised. Any material able to immobilise a water immiscible solvent can be used. Hydrophobic hollow fibres are particularly useful. The fibres can be made of a polymeric materials such as Teflon, polypropylene or polyethylene. The inner diameter of the hollow fibre is in the range of 0.05 1 mm, the wall thickness is typically in the range of 0.01 0.3 mm and the average pore size is in the range of 0.01 10 jpm. The length of the fibre is typically 2 10 cm to allow fixed volumes of acceptor solution in the range of 5 50 tl to be filled into the hollow fibre.
WO 00/33050 PCT/N099/00359 11 In LSLME the membrane may be a polymeric film made of a materiale able to sorb uncharged compounds. Examples of such materials are polydimethylsiloxane (PDMS), polyacrylate or polystyrene divinyl benzene. These materials are also used as well known sorbents in SPME. The membrane thickness is preferably 0.5 50 pIm. The membrane may be supported by a rigid framework and formed into tubes with the same dimensions as the hollow fibres described above.
Devices for LLLME should be disposable. Impurities from one sample may be trapped in the membrane and these impurities may contaminate other samples. One sample pretreatment device should therefore be used for each sample. Disposable devices should also be connected to commercially available sample preparation vials.
Disposable devices for LLLME are shown in Figures 3a and 4a. Figures 3b and 4b show the devices connected to sample vials filled with sample solution. The guiding rod can be a stainless steel rod or a rod made of a polymeric material. The top of the guiding rod can be connected to a needle guide to allow filling of the hollow fibre with acceptor solution from a syringe. The hollow fibre in Fig. 3b is connected at both ends to guiding rods.
Sample preparation with disposable LLLME devices In LSLME the membrane can be used as it is. In LLLME the liquid membrane is formed by dipping the hollow fibre into the organic solvent for 5-30 sec. to allow the solvent to penetrate into the pores of the fibre. Acceptor solution is then filled into the fibre by a syringe. Normally, fibres with an inner tube volume of 10 p1 are preferred, since 10 p.1 of acceptor solution gives high analyte enrichments and 10 pl volumes can be handled with commercially available syringes. The acceptor solution has a pH where the target analytes are charged. Extraction is performed by connecting the LLLME device to the sample vial. The sample filled into the sample vial is buffered to a pH where the analytes are neutral. Typical sample volumes are 0.5 5 ml of a biological fluid. An internal standard is always added to the sample solution before extraction to compensate for fluctuations in the procedure. Extraction is performed by stirring, for example with a magnetic stir bar placed in the sample vial. Extraction is continued until equilibrium between the three phases is established. When equilibrium is reached min) the acceptor solution is collected with a syringe and filled into autosampler vials for automated injection into the analytical instrument.
WO 00/33050 PCT/N099/00359 12 The invention will now be illustrated in more detail with the aid of the following examples.
The device shown in Figure 4a was used to demonstate the potential of liquid-liquid micro extraction and liquid-liquid-liquid micro extraction. The hollow fibre used was a polypropylene fibre with pore size 0.2 p.m (Accurel PP Q3/2) and was purchased from Akzo Nobel (Wuppertal, Germany). The inner diameter was 600 gm, the wall thickness was 200 gm and the length was 5.5 cm.
Example 1: Liquid liquid micro extraction (LLME) LLME is demonstrated by the extraction of 5 nmol/ml sample solutions of diazepam and prazepam prepared in 1.0 M acetate buffer pH 5.5, in urine and in human plasma. A standard solution in octanol (5 nmol/ml) was prepared as a reference solution for direct injection into the gas chromatograph. The pH of the standard solution in urine was adjusted to pH 5.5 before extraction. To an aliquote of plasma (1080 pl) was added 120 gl methanol to reduce the protein binding of the benzodiazepines prior to extraction and the mixture was agitated for 1 min. LLME was accomplished by placing 1.2 ml of the sample solutions in 2 ml autosampler vials (Chromacol, Trumball, CT., USA). The hollow fibre was filled with 10 ul of 1-octanol. After 1 min, to ensure that the solvent would completely penetrate the pores, the hollow fibre was immersed into the autosampler vials. The sample solution was stirred with a magnetic stir bar during extraction. After 30 min 1 pl of octanol was withdrawn from the hollow fibre with a GC syringe and injected into the gas chromatograph. The gas chromatographic separation was achieved on a poly-(dimethylsiloxane) column (30 x 0.25 mm 0.25 mm film thickness) and the compounds were detected with a nitrogen-phosphorous detector (NPD). Helium (1 ml/min) was used a carrier gas. The chromatographic separation was achieved by temperature programming. The temperature was held at 180 0 C for 1 min and increased at 20 C /min to 300 0 C. Figure 5 shows chromatograms of the reference solution in octanol (5 nmol/ml) and chromatograms of the sample solutions (5 nmol/ml) of diazepam and prazepam in acetate buffer, in urine and plasma after enrichment by LLME. The chromatograms demonstrate preconcentration by a factor of 100 and respectively, for diazepam and prazepam from the acetate buffer, urine and the plasma sample.
Example 2: Liquid-liquid-liquid micro extraction (LLLME) LLLME is performed with 1-octanol as the immobilised liquid. The hollow fibre was immersed for 5 sec in 1-octanol which is sufficient for 1-octanol to penetrate and fill the WO 00/33050 PCT/N099/00359 13 pores of the fibre. 10 al of 0.1M HCI was used as acceptor solution and was filled into the impregated fibre with a syringe. A standard solution of 4 Pg/ml of diphenhydramine in 0.1 M HCI was prepared as a reference for direct injection into the CE instrument. In addition, sample solutions of diphenydramine (4 pg/ml) were prepared in 0.1 M NaOH, in urine and plasma. Before extraction the pH in the urine and plasma sample solutions were adjusted to a pH 12-13 with NaOH. 1.5 ml of the sample solutions were placed in 2 ml autosampler vials. LLLME was accomplished by stirring with a magnetic stir bar for 30 min. The acceptor solution was removed after extraction and analysed by CE.
Separations were perfomed inside a 10 cm effective length (52 cm total length) x 50 gm internal diameter fused silica capillary. A 20 mM sodium acetate buffer adjusted to pH with acetic acid was utilised as separation buffer. Sample introduction was accomplished by hydrodynamic injection with a pressure of 0.5 psi for 5 sec.
Separations were performed at 25 kV, while detection was accomplished at 215 nm.
Electropherograms are shown in Figure 6. The electropherograms show that diphenhydramine (DH) was preconcentrated by a factor of 90 from the sample solution prepared in 0.1 M NaOH and in urine. A preconcentration of 50 was achieved from plasma. The lower enrichment from plasma is due to protein binding of the analyte. For both of the biological samples, excellent sample clean-up was observed in addition to analyte enrichment. In spite of the high sample complexity, almost no matrix components were observed in the electropherograms obtained by capillary zone electrophoresis.
Claims (12)
1. Apparatus for carrying out liquid-liquid micro extraction or liquid-liquid- liquid micro extraction with high enrichment including, a) a container for a sample solution having volume Vs with dissolved substance, analyte, to be analysed, b) a second container arranged in the first container, preferably a disposable container, having permeable membrane walls, for an acceptor solution, having volume Va, wherein 1) Vs:Va 2 50 and 2) about 1 pl Va 50 pl, c) stirring means, preferably a magnetic bar.
2. Apparatus according to 1, wherein the container for the acceptor solution 15 is a microporous hollow fibre.
3. Apparatus according to claim 2, wherein the container is a hollow fibre of an active polymer. 20
4. A method for liquid-liquid micro extraction with high enrichment by the use of the apparatus according to claim 1, 2 or 3, wherein a) the container for acceptor solution is lowered into an acceptor solution so that the membrane wall is impregnated with and the container is filled with a defined volume of the acceptor solution, b) the container filled under a) is transferred to the container having a defined volume of the sample solution with the analyte that is sought, c) the sample solution with analyte is stirred until extraction equilibrium is established for the analyte in the two solutions, and d) the acceptor solution containing enriched analyte is removed from its container for analysis of the analyte.
A method for liquid-liquid-liquid micro extraction with high enrichment by the use of the apparatus according to claim 1, 2 or 3, wherein W:\DELILAH\DCNODELEM16986-00 CLAIMS.doc a) the walls of the container for the acceptor solution are impregnated with, for immobilisation of, a liquid that is immiscible with the sample solution and the acceptor solution, b) the container for acceptor solution is filled with a defined volume thereof and c) is lowered into the container having a defined volume of the sample solution with the analyte that is sought, d) the sample solution with analyte is stirred until extraction equilibrium is established between i) the sample solution and the immobilised liquid, and ii) the immobilised liquid and the acceptor solution, and e) the acceptor solution with enriched analyte is removed from its container for analysis of the analyte.
6. A method according to claim 4 or 5, wherein a microporous hollow fibre is used as the container for acceptor liquids.
7. A method according to claim 5, wherein a microporous hollow fibre made of an active polymer is used as the container for the acceptor liquid.
8. A method according to any one of claims 5 to 7, wherein both the sample solution and the acceptor solution are aqueous liquids.
9. A method according to claim 8, wherein the liquid immobilised in the membrane is an organic liquid immiscible with aqueous liquids.
A method according to any one of claims 5 to 9, wherein the sample solution is a basic, aqueous biological sample and the acceptor solution is an acidified, aqueous liquid for extraction of basic analytes.
11. Apparatus for carrying out liquid-liquid micro extraction or liquid-liquid- liquid micro extraction, with high enrichment, substantially as herein described with reference to the figures. W:ADELILAH\DCNODELE\16986-00 CLAIMS.doc 16
12. A method for liquid-liquid micro extraction or liquid-liquid-liquid micro extraction, with high enrichment, substantially as herein described with reference to the figures. DATED: 6 August, 2003 PHILLIPS ORMONDE FITZPATRICK Attorneys for: KNUT E RASMUSSEN, METTE KROGH and STIG PEDERSEN-BJERGAARD ee W:\DELILAH\DCNODELE\16986.00 CLAIMS.doc
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2004200049A AU2004200049B2 (en) | 1998-12-01 | 2004-01-07 | Method and disposable devices for micro extraction |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO19985613 | 1998-12-01 | ||
| NO19985613A NO311464B1 (en) | 1998-12-01 | 1998-12-01 | Process and disposable micro-extraction device |
| PCT/NO1999/000359 WO2000033050A1 (en) | 1998-12-01 | 1999-11-30 | Method and disposable devices for micro extraction |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2004200049A Division AU2004200049B2 (en) | 1998-12-01 | 2004-01-07 | Method and disposable devices for micro extraction |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU1698600A AU1698600A (en) | 2000-06-19 |
| AU766012B2 true AU766012B2 (en) | 2003-10-09 |
Family
ID=19902679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU16986/00A Ceased AU766012B2 (en) | 1998-12-01 | 1999-11-30 | Method and disposable devices for micro extraction |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1137924A1 (en) |
| JP (1) | JP2002531823A (en) |
| AU (1) | AU766012B2 (en) |
| CA (1) | CA2353130C (en) |
| NO (1) | NO311464B1 (en) |
| WO (1) | WO2000033050A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002042500A2 (en) * | 2000-10-31 | 2002-05-30 | Hitachi Chemical Research Center, Inc. | Apparatus and method for electrophoretic microspot concentration |
| WO2002088671A1 (en) * | 2001-04-26 | 2002-11-07 | Esytech Ab | A separation unit, a method for separation, and a device for mounting a separation unit in a separation apparatus |
| JP2004535563A (en) * | 2001-04-26 | 2004-11-25 | ヴァリアン インコーポレーテッド | Sample preparation device for hollow fiber membranes |
| US7445939B2 (en) | 2004-02-27 | 2008-11-04 | Varian, Inc. | Stable liquid membranes for liquid phase microextraction |
| NO20053226D0 (en) * | 2005-06-30 | 2005-06-30 | Uni I Oslo | Procedure for Electrokinetic Migration. |
| JP4736130B2 (en) * | 2006-02-20 | 2011-07-27 | 株式会社島津製作所 | Chromatographic analysis of readily soluble organic solvents in sample water |
| EP2461150B1 (en) | 2010-12-06 | 2019-11-06 | Greibrokk & Trones Septech AS | Device and process for electro membrane extraction (EME) |
| CN102974127B (en) * | 2012-11-23 | 2017-12-08 | 中国计量学院 | A kind of hollow-fibre membrane micro-extraction apparatus and its application |
| CN103877746B (en) * | 2012-12-21 | 2016-06-15 | 中国科学院大连化学物理研究所 | A kind of method regulating electric drive liquid-liquid-liquid extraction polarity anion selectivity |
| CN104034572A (en) * | 2014-06-24 | 2014-09-10 | 广西中烟工业有限责任公司 | Carotenoid hollow fiber membrane liquid-phase micro-extraction method |
| US10272389B2 (en) | 2017-04-04 | 2019-04-30 | Extraction Technologies Norway AS | Devices for electromembrane extraction (EME) |
| CN110935194B (en) * | 2019-12-12 | 2021-08-06 | 中国计量大学 | A hollow fiber membrane microextraction system |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991015745A1 (en) * | 1990-04-02 | 1991-10-17 | Pawliszyn Janusz B | Method and device for solid phase microextraction and desorption |
| DE19525771A1 (en) * | 1994-09-15 | 1996-03-28 | Hewlett Packard Co | Liquid samples extraction, minimising the requirement for solvents |
| WO1997025606A1 (en) * | 1996-01-11 | 1997-07-17 | Rasmussen Knut E | Method for liquid-liquid microextraction |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5732701A (en) * | 1980-08-07 | 1982-02-22 | Agency Of Ind Science & Technol | Solute permeating device |
| JPS61204004A (en) * | 1985-03-06 | 1986-09-10 | Hitachi Zosen Corp | Solvent extraction method |
| US4963264A (en) * | 1985-06-10 | 1990-10-16 | The Standard Oil Company | Process for selective dialysis using polymeric affinity adsorbents and size selective membranes |
| US5277821A (en) * | 1989-09-25 | 1994-01-11 | Symbiotech Incorporated | Purification of samples by interphase mass transfer using microporous hollow-fiber membranes |
| JPH09299707A (en) * | 1996-05-17 | 1997-11-25 | Shimadzu Corp | Concentration extraction and removal device for chemical substances |
| EP0918563A1 (en) * | 1996-08-12 | 1999-06-02 | Hampshire Advisory and Technical Services Limited | Diagnostic test container |
| JP3652049B2 (en) * | 1997-02-21 | 2005-05-25 | 栄研器材株式会社 | Wiping device for environmental microbiological examination |
-
1998
- 1998-12-01 NO NO19985613A patent/NO311464B1/en not_active IP Right Cessation
-
1999
- 1999-11-30 JP JP2000585638A patent/JP2002531823A/en active Pending
- 1999-11-30 AU AU16986/00A patent/AU766012B2/en not_active Ceased
- 1999-11-30 CA CA002353130A patent/CA2353130C/en not_active Expired - Fee Related
- 1999-11-30 WO PCT/NO1999/000359 patent/WO2000033050A1/en not_active Ceased
- 1999-11-30 EP EP99960040A patent/EP1137924A1/en not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991015745A1 (en) * | 1990-04-02 | 1991-10-17 | Pawliszyn Janusz B | Method and device for solid phase microextraction and desorption |
| DE19525771A1 (en) * | 1994-09-15 | 1996-03-28 | Hewlett Packard Co | Liquid samples extraction, minimising the requirement for solvents |
| WO1997025606A1 (en) * | 1996-01-11 | 1997-07-17 | Rasmussen Knut E | Method for liquid-liquid microextraction |
Also Published As
| Publication number | Publication date |
|---|---|
| AU1698600A (en) | 2000-06-19 |
| NO311464B1 (en) | 2001-11-26 |
| CA2353130A1 (en) | 2000-06-08 |
| JP2002531823A (en) | 2002-09-24 |
| NO985613L (en) | 2000-06-02 |
| NO985613D0 (en) | 1998-12-01 |
| EP1137924A1 (en) | 2001-10-04 |
| WO2000033050A1 (en) | 2000-06-08 |
| CA2353130C (en) | 2009-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Psillakis et al. | Developments in liquid-phase microextraction | |
| Rasmussen et al. | Developments in hollow fibre-based, liquid-phase microextraction | |
| Pedersen-Bjergaard et al. | Liquid-phase microextraction with porous hollow fibers, a miniaturized and highly flexible format for liquid–liquid extraction | |
| Rasmussen et al. | Development of a simple in-vial liquid-phase microextraction device for drug analysis compatible with capillary gas chromatography, capillary electrophoresis and high-performance liquid chromatography | |
| Tobiszewski et al. | Green analytical chemistry in sample preparation for determination of trace organic pollutants | |
| Kataoka | Recent advances in solid-phase microextraction and related techniques for pharmaceutical and biomedical analysis | |
| Sarafraz-Yazdi et al. | BTEX determination in water matrices using HF-LPME with gas chromatography–flame ionization detector | |
| Lancas et al. | Recent developments and applications of stir bar sorptive extraction | |
| Ghambarian et al. | Developments in hollow fiber based liquid-phase microextraction: principles and applications | |
| Pawliszyn et al. | Analytical microextraction: current status and future trends | |
| Mao et al. | Membrane protected C18 coated stir bar sorptive extraction combined with high performance liquid chromatography-ultraviolet detection for the determination of non-steroidal anti-inflammatory drugs in water samples | |
| Saito et al. | Direct coupling of microcolumn liquid chromatography with in-tube solid-phase microextraction for the analysis of antidepressant drugs | |
| AU766012B2 (en) | Method and disposable devices for micro extraction | |
| JP2004535563A (en) | Sample preparation device for hollow fiber membranes | |
| Armenta et al. | Design and evaluation of a coupled monolithic preconcentrator-capillary zone electrophoresis system for the extraction of immunoglobulin G from human serum | |
| Flanagan et al. | Micro‐extraction techniques in analytical toxicology: short review | |
| Almeda et al. | Direct determination of chlorophenols present in liquid samples by using a supported liquid membrane coupled in-line with capillary electrophoresis equipment | |
| WO2001031330A1 (en) | Liquid-liquid extraction device and on-line transfer to a gas chromatography apparatus | |
| Norberg et al. | Extracting syringe—connecting sample preparation and gas chromatography | |
| Pedersen-Bjergaard | Microextraction with supported liquid membranes | |
| De la Guardia et al. | Greening sample treatments | |
| AU2004200049B2 (en) | Method and disposable devices for micro extraction | |
| CA2242481C (en) | Method for liquid-liquid microextraction | |
| Owczarek et al. | New achievements in the field of extraction of trace analytes from samples characterized by complex composition of the matrix | |
| Majors | Miniaturized approaches to conventional liquid–liquid extraction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |